WinstonWınston
Back

This stock no longer trades (delisted May 15, 2026)

Delisted / no longer publicly traded (per market data provider) Everything below is based on the last available data — treat it as historical, not a live read.

Enhabit logo

Enhabit

EHAB
40
Medical - Care Facilities · Healthcare
Price
$13.80
+0.01 (+0.07%)
Market Cap
$706.9M
Winston Score
40
Historical score — this stock no longer trades, so the score is frozen at the last available data.
Data as of Aug 23, 2026 · filings through Mar 31, 2026
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Weak
Stability
Good
Valuation
Data not available

Share count rising — dilution

+1202.6% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 3.9M (2021) → 50.8M (2025)

Winston Score History

The full picture

Enhabit, Inc. provides home health and hospice care services across the United States. The company sends nurses and therapists directly to patients' homes to help them recover from surgeries, manage chronic illnesses, or receive end-of-life care. It is one of the larger independent home health and hospice providers in the country, serving Medicare and Medicaid patients as its primary customer base.

Enhabit earns most of its revenue through reimbursements from government payers, mainly Medicare, which sets the rates it receives for each episode of care. The company operates hundreds of locations across roughly 30 states, giving it a broad geographic footprint compared to smaller regional competitors. Its main challenge is thin profitability — the negative return on invested capital signals the business is not yet earning back what it spends — and ongoing pressure from Medicare reimbursement rate changes could further squeeze margins in the near term.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+1.9% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+8.6% YoY

YoY Growth Rate

Slow EPS growth

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

12.9%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$52M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Enhabit is growing revenue at 2% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
47.6%
Healthy — 47.6% gross margin
Profit after running costs
Operating Margin
11.1%
Modest — 11.1% operating margin
Return on the money invested
ROCE
7.9%
Weak — 7.9% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+3.2%
Slow sales growth (+3.2% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
7.6%
Modest free cash flow (7.6%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.77
Moderate — manageable debt (0.77)
Covers its interest
Interest Cover
2.23x
Tight — interest eats into profit (2.2x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial